F. Cholet (Praticien hospitalier) , J.-B. Nousbaum (Professeur des Universités, praticien hospitalier) , N. Lagarde (Professeur des Universités, praticien hospitalier) , B. Turlin (Maître de conférences des Universités, praticien hospitalier)
{"title":"肝细胞癌以外的原始肝恶性肿瘤","authors":"F. Cholet (Praticien hospitalier) , J.-B. Nousbaum (Professeur des Universités, praticien hospitalier) , N. Lagarde (Professeur des Universités, praticien hospitalier) , B. Turlin (Maître de conférences des Universités, praticien hospitalier)","doi":"10.1016/j.emchg.2004.12.003","DOIUrl":null,"url":null,"abstract":"<div><p>Malignant primary tumours other than hepatocellular carcinoma are rare. They represent 2% to 3% of the gastrointestinal tract tumours. Unlike hepatocellular carcinoma, they develop most of the time in a non cirrhotic liver. These tumours may derive from the hepatocyte, cholangiocyte, mesenchymatous cells, or endocrine cells. Despite the fact that clinical and imaging features may suggest the nature of the tumour, the final diagnosis is based on the histopathologic examination of a liver biopsy or a surgical fragment.</p></div>","PeriodicalId":100426,"journal":{"name":"EMC - Hépato-Gastroenterologie","volume":"2 1","pages":"Pages 19-27"},"PeriodicalIF":0.0000,"publicationDate":"2005-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emchg.2004.12.003","citationCount":"3","resultStr":"{\"title\":\"Tumeurs hépatiques malignes primitives en dehors du carcinome hépatocellulaire\",\"authors\":\"F. Cholet (Praticien hospitalier) , J.-B. Nousbaum (Professeur des Universités, praticien hospitalier) , N. Lagarde (Professeur des Universités, praticien hospitalier) , B. Turlin (Maître de conférences des Universités, praticien hospitalier)\",\"doi\":\"10.1016/j.emchg.2004.12.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Malignant primary tumours other than hepatocellular carcinoma are rare. They represent 2% to 3% of the gastrointestinal tract tumours. Unlike hepatocellular carcinoma, they develop most of the time in a non cirrhotic liver. These tumours may derive from the hepatocyte, cholangiocyte, mesenchymatous cells, or endocrine cells. Despite the fact that clinical and imaging features may suggest the nature of the tumour, the final diagnosis is based on the histopathologic examination of a liver biopsy or a surgical fragment.</p></div>\",\"PeriodicalId\":100426,\"journal\":{\"name\":\"EMC - Hépato-Gastroenterologie\",\"volume\":\"2 1\",\"pages\":\"Pages 19-27\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2005-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.emchg.2004.12.003\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EMC - Hépato-Gastroenterologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1769676304000229\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMC - Hépato-Gastroenterologie","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1769676304000229","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Tumeurs hépatiques malignes primitives en dehors du carcinome hépatocellulaire
Malignant primary tumours other than hepatocellular carcinoma are rare. They represent 2% to 3% of the gastrointestinal tract tumours. Unlike hepatocellular carcinoma, they develop most of the time in a non cirrhotic liver. These tumours may derive from the hepatocyte, cholangiocyte, mesenchymatous cells, or endocrine cells. Despite the fact that clinical and imaging features may suggest the nature of the tumour, the final diagnosis is based on the histopathologic examination of a liver biopsy or a surgical fragment.